Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Kidney Cancer is Scopus-indexed (Q3, CiteScore 1.7), WoS ESCI, DOAJ. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 2468-4562Verify ISSN ↗2468-4570Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Nephrology | 53 / 88 | 40th | Q3 |
| Oncology | 302 / 428 | 29th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2017–2025, best quartile Q3, CiteScore 1.7.
Kidney Cancer is Q3 in Nephrology (rank 53 of 88) and Q3 in Oncology (rank 302 of 428), by CiteScore 2025.
Kidney Cancer is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.7, which places it in quartile Q3 at the 40th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.488, quartile Q2, with an H-index of 13.
Kidney Cancer is published by SAGE Publications Ltd. Its print ISSN is 2468-4562 and its online ISSN is 2468-4570.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Kidney Cancer has an h-index of 15 and a 2-year mean of 1.38 citations per paper (OpenAlex). Its Scopus CiteScore is 1.7, quartile Q3. On 2-year citations it ranks #40 of 87 Scopus journals in Nephrology.
Kidney Cancer published 9 papers in 2025; its busiest recent year was 2019 with 53. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 92 research articles (2021–2026), authors are most often from United States (69%), United Kingdom (4.6%) and Brazil (3.8%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.